Background illustration for clinical trials search

Alopecia Clinical Trials

Browse 58 Alopecia clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Biocellular-Cellular Regenerative Treatment Scaring Alopecia and Alopecia Areata

for
Alopecia Areata, Scarring Alopecia
Location: North Attleboro MA, Stevensville MT, Irvine CA
Sponsor: Regeneris Medical

Sex: All

Age: 18 - 70+

Code: NCT03078686

Recruiting

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indications and Solid Tumors

for
Alopecia
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 7+

Code: NCT04764357

Recruiting

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

for
Alopecia Areata
Location: Waltham MA
Sponsor: CorEvitas

Sex: All

Age: 18+

Code: NCT05745389

Recruiting

Dupilumab in the Treatment of Pediatric Alopecia Areata

for
Alopecia Areata
Location: New York NY, Chicago IL, San Diego CA, Irvine CA
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 6 - 17

Code: NCT05866562

Phase 2, Recruiting

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

for
Alopecia, Chemotherapy-induced Alopecia, Hair Loss,
Location: Urbana IL, Tucson AZ
Sponsor: Cooler Heads Care Inc.

Sex: Female

Age: 21+

Code: NCT05484973

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia

for
Central Centrifugal Cicatricial Alopecia
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: Female

Age: 18 - 70+

Code: NCT04764331

Recruiting

Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

for
Central Centrifugal Cicatricial Alopecia (CCCA)
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: Female

Age: 18 - 60

Code: NCT04207931

Recruiting

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

for
Alopecia Areata
Location: Fairfield CT, Baltimore MD, Rockville MD, Miami FL,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT06873945

Phase 3, Recruiting

Blood Specimen Collection For Laboratory Assay Research

for
General; Metabolic Disorder, Sexual Dysfunction, Hair Loss,
Location: San Francisco CA
Sponsor: Roman Health Ventures Inc.

Sex: All

Age: 18+

Code: NCT06046651

Recruiting

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

for
Scarring Alopecia, Androgenetic Alopecia
Location: Elmsford NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18 - 70+

Code: NCT05460611

Recruiting

A Study of LAD603 in Adults With Alopecia Areata

for
Alopecia Areata
Location: Omaha NE
Sponsor: Almirall, S.A.

Sex: All

Age: 18 - 65

Code: NCT07311564

Phase 2, Recruiting

Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

for
Atopic Dermatitis, Alopecia Areata
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 12+

Code: NCT07242638

Phase 2, Recruiting

A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata

for
Alopecia Areata
Location: Plymouth Meeting PA, Miami FL, Troy MI, Indianapolis IN,
Sponsor: Pfizer

Sex: All

Age: 12+

Code: NCT07733765

Phase 3, Recruiting

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

for
Severe Alopecia Areata
Location: Miami FL, Indianapolis IN, Papillion NE, Omaha NE,
Sponsor: Pfizer

Sex: All

Age: 6 - 14

Code: NCT07029828

Phase 3, Recruiting

Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata

for
Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (Apeced),
Location: Bethesda MD
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 12 - 70+

Code: NCT05398809

Phase 2, Recruiting

Safety and Biomarker Responses of Delgocitinib (JAK1,2,3/TYK2 Inhibitor) in Central Centrifugal Cicatricial Alopecia and Lichen Planopilaris

for
Central Centrifugal Cicatricial Alopecia, Lichen Planopilaris
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT07487948

Phase 2, Recruiting

Deucravacitinib in the Treatment of Cicatricial Alopecias

for
Central Centrifugal Cicatricial Alopecia,
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18+

Code: NCT07508488

Phase 2, Recruiting

Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata

for
Alopecia Areata
Location: Verona NJ, Plymouth Meeting PA, Rockville MD, Cary NC,
Sponsor: Sun Pharmaceutical Industries, Inc.

Sex: All

Age: 12 - 17

Code: NCT07133308

Phase 3, Recruiting

Excimer Light for Alopecia Areata

for
Alopecia Areata
Location: Vancouver
Sponsor: University of British Columbia

Sex: All

Age: 19+

Code: NCT01802177

Phase 2, Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata

for
Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases,
Location: The Bronx NY, Norfolk VA, Rockville MD, Miami FL,
Sponsor: Eli Lilly and Company

Sex: All

Age: 6 - 17

Code: NCT05723198

Phase 3, Recruiting

What is alopecia, and what are the types?

"Alopecia" does not name one disease. The most common type is androgenetic alopecia, hereditary pattern hair loss, which affects about 80 million people in the US, 50 million men and 30 million women; studies of its treatments are on our hair loss treatment trials page. Alopecia areata is an autoimmune type that causes round patches and has its own alopecia areata clinical trials page. Telogen effluvium is heavy shedding a few months after stress, illness, or childbirth, and it usually recovers on its own. Traction alopecia comes from hairstyles that pull for a long time; caught early it can recover, but after years of pulling the loss becomes permanent. Hair loss from chemotherapy is usually temporary.

Then there are the scarring alopecias, where inflammation destroys the follicle and replaces it with scar tissue. Central centrifugal cicatricial alopecia (CCCA) starts at the crown and spreads outward. It is the most common cause of scarring hair loss in African American women, affecting an estimated 2.7 to 5.6 percent of Black women, and it runs in families. Frontal fibrosing alopecia (FFA) and lichen planopilaris are more often seen in White patients, and FFA typically causes a receding band along the front hairline. There is no cure, and no medicine has been approved by the FDA for any scarring alopecia, so the goal of treatment is to stop the damage. It is surprising, but most of the medicine trials for these conditions only started in the last few years.

Types of alopecia clinical trials

Who can participate in alopecia clinical trials?

Scarring or non scarring: why the difference matters for trials

Is alopecia genetic?

Do alopecia trial participants get paid?

How to enroll in an alopecia clinical trial